{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:45:22Z","timestamp":1785908722041,"version":"3.56.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Premature ovarian insufficiency (POI) is characterized by impaired ovarian endocrine function and reduced ovarian reserve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched eight bibliographic databases, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and the Chinese Clinical Trial Registry (ChiCTR) from inception to May 30, 2026, for parallel-group randomized controlled trials comparing HRT-based regimens with pure oral Chinese herbal formulas within three prespecified therapeutic-principle categories. This systematic review was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD420251234457).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Menstrual return or resumption was designated as the patient-important outcome, while follicle-stimulating hormone (FSH) and anti-M\u00fcllerian hormone (AMH) were designated as primary surrogate biomarkers. Forty-one HRT-controlled trials met the prespecified therapeutic-principle criteria. No clear between-group difference was detected for menstrual return or resumption (4 studies, 266 participants; odds ratio [OR] 1.523, 95% confidence interval [CI] 0.315 to 7.371; I\n                      <jats:sup>2<\/jats:sup>\n                      = 86.16%). Point estimates favored oral herbal formulas for FSH (37 studies; mean difference [MD] \u22125.563, 95% CI \u22128.230 to \u22122.896; I\n                      <jats:sup>2<\/jats:sup>\n                      = 99.13%) and AMH (12 studies; MD 0.167, 95% CI 0.035 to 0.299; I\n                      <jats:sup>2<\/jats:sup>\n                      = 98.17%), but both were surrogate outcomes and their prediction intervals crossed the null. Directionally favorable estimates were also observed for luteinizing hormone (LH), estradiol (E2), antral follicle count (AFC), and peak systolic velocity (PSV), although these were surrogate or exploratory outcomes with substantial uncertainty. Fewer adverse events were reported with oral herbal formulas, but safety remained unestablished because ascertainment and reporting were incomplete. Therapeutic-principle analyses yielded an exploratory subgroup signal only for FSH and did not establish comparative superiority among kidney-tonifying alone (PK), kidney-tonifying and liver-soothing (KL), and kidney-tonifying and blood-activating (KB) categories. All assessed outcomes were rated as very low-certainty evidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Current evidence does not support the routine use of any specific Chinese herbal formula or therapeutic-principle category. Guideline-based management, including HRT when clinically appropriate, should remain standard care, and rigorously designed multicenter trials using patient-important outcomes and standardized safety reporting are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      , identifier CRD420251234457.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1870487","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:54:38Z","timestamp":1785905678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral Chinese herbal formulas for premature ovarian insufficiency: a systematic review, meta-analysis, and exploratory therapeutic-principle subgroup analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yihong","family":"Wu","sequence":"first","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[{"name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guichun","family":"Liu","sequence":"additional","affiliation":[{"name":"Faculty of Health and Physical Education, Xi\u2019an Fanyi University","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurui","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Basic Medicine, Shaanxi University of Chinese Medicine","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Cheng","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Xuzhou Medical University","place":["Xuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Faculty of Health and Physical Education, Xi\u2019an Fanyi University","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5114\/pm.2018.78550","article-title":"Premature ovarian insufficiency - aetiopathology, epidemiology, and diagnostic evaluation","volume":"17","author":"Rudnicka","year":"2018","journal-title":"Prz Menopauzalny"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2010.488773","article-title":"Premature ovarian failure from current perspective","volume":"26","author":"Kokcu","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2020.1804547","article-title":"Premature ovarian insufficiency: an International Menopause Society white paper","volume":"23","author":"Panay","year":"2020","journal-title":"Climacteric"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.224","article-title":"Anti-M\u00fcllerian hormone: an ovarian reserve marker in primary ovarian insufficiency","volume":"8","author":"Visser","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1172481","article-title":"Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants","volume":"14","author":"Shi","year":"2023","journal-title":"Front Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13697137.2025.2530441","article-title":"Complementary therapies for women with premature ovarian insufficiency: a systematic literature review to inform the 2024 update of the Eshre\/Asrm\/Ims\/Cre-Whirl guidelines on premature ovarian insufficiency","volume":"29","author":"Maunder","year":"2026","journal-title":"Climacteric"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1789304","article-title":"Efficacy of traditional Chinese medicine tonifying kidney (Bushen) and activating blood (Huoxue) prescription for premature ovarian insufficiency: a systematic review and meta-analysis","volume":"2020","author":"Li","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.132981.1","article-title":"Identifying the most effective traditional Chinese medicine treatment modalities for premature ovarian insufficiency: a systematic review and network meta-analysis [version 1; peer review: 1 approved with reservations, 1 not approved]","volume":"12","author":"Sin","year":"2023","journal-title":"F1000Research"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.21010\/ajtcam.v13i5.21","article-title":"Traditional Chinese medicine combined with hormone therapy to treat premature ovarian failure: a meta-analysis of randomized controlled trials","volume":"13","author":"Kou","year":"2016","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The Prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0808697","article-title":"Primary ovarian insufficiency","volume":"360","author":"Nelson","year":"2009","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12874-018-0483-0","article-title":"Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review","volume":"18","author":"Weir","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060410","article-title":"The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey","volume":"176","author":"Ioannidis","year":"2007","journal-title":"Can Med Assoc J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"Grade guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7620\/zgfybj.j.issn.1001-4411.2019.08.44","article-title":"Clinical study of Bushen Tiaojing formula combined with hormone replacement therapy for premature ovarian failure","volume":"34","author":"Chen","year":"2019","journal-title":"Matern Child Health Care China"},{"key":"B20","first-page":"71","article-title":"Effect of Bushen Tiaojing paste formula on sex hormone levels in patients with kidney-deficiency-type premature ovarian failure","volume":"23","author":"Chen","year":"2017","journal-title":"Psychologist"},{"key":"B21","article-title":"Clinical efficacy of modified Yuyinling for liver-kidney yin-deficiency-type premature ovarian failure and its regulation of the hypothalamic-pituitary-ovarian axis [Article in Chinese]","volume":"31","author":"Cheng","year":"2016","journal-title":"Matern Child Health Care China"},{"key":"B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.16305\/j.1007-1334.2020.08.011","article-title":"Clinical observation of Bushen Huoxue decoction in the treatment of premature ovarian failure and its influence on Ana-Aca-Aoa pathway","volume":"54","author":"Dong","year":"2020","journal-title":"Shanghai J Tradit Chin Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3969\/j.issn.2096-3327.2024.07.001","article-title":"Effects of Bushen Huoxue formula combined with estradiol tablets\/estradiol and dydrogesterone tablets on traditional Chinese medicine syndrome, ovarian reserve function and T cell subsets in patients with premature ovarian failure","volume":"21","author":"Dong","year":"2024","journal-title":"Chin J Ration Drug Use"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.16367\/j.issn.1003-5028.2024.09.0240","article-title":"Clinical study on modified channel-warming decoction in the treatment of premature ovarian failure","volume":"44","author":"Feng","year":"2024","journal-title":"Henan Tradit Chin Med"},{"key":"B25","article-title":"Clinical observation of Bushui Roumu formula plus medroxyprogesterone acetate for premature ovarian failure with kidney deficiency and liver depression [Article in Chinese]","volume":"32","author":"Hua","year":"2012","journal-title":"Chin J Integr Tradit West Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.13192\/j.issn.1000-1719.2023.10.028","article-title":"Clinical efficacy of Zishen Yutai pills combined with Yulin pearls for premature ovarian failure treated from the perspective of Qi and their effects on serum Amh and Inhb levels [Article in Chinese]","volume":"50","author":"Huang","year":"2023","journal-title":"Liaoning J Tradit Chin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.16254\/j.cnki.53-1120\/r.2016.11.011","article-title":"Clinical observation on treatment of premature ovarian failure by tonifying kidney and regulating periods","volume":"37","author":"Jiang","year":"2016","journal-title":"Yunnan J Tradit Chin Med Mater Med"},{"key":"B28","article-title":"Clinical study of Bushen Huoxue formula combined with estrogen-progestogen therapy for premature ovarian failure [Article in Chinese]","volume":"33","author":"Jin","year":"2013","journal-title":"Chin J Integr Tradit West Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2020.01.033","article-title":"Clinical study on modified Guixian Tang combined with Femonston for premature ovarian failure of kidney deficiency and liver depression type","volume":"52","author":"Li","year":"2020","journal-title":"J New Chin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.16368\/j.issn.1674-8999.2018.04.152","article-title":"Clinical study of Bushen Shugan formula combined with an artificial cycle for premature ovarian failure with kidney deficiency and liver depression [Article in Chinese]","volume":"33","author":"Li","year":"2018","journal-title":"Acta Chin Med"},{"key":"B31","article-title":"Clinical observation of modified Erxian decoction for premature ovarian insufficiency with spleen-kidney yang deficiency [Article in Chinese]","volume":"33","author":"Li","year":"2018","journal-title":"Acta Chin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1003-8914.2012.08.052","article-title":"Traditional Chinese medicine as an alternative to hormone therapy for premature ovarian failure [Article in Chinese]","volume":"27","author":"Li","year":"2012","journal-title":"Guangming J Chin Med"},{"key":"B33","article-title":"Clinical study of a kidney-tonifying, blood-activating, and dampness-eliminating method for infertility due to premature ovarian insufficiency [Article in Chinese]","volume":"42","author":"Ling","year":"2021","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.13935\/j.cnki.sjzx.190323","article-title":"Clinical research of Bushen Tiaojing cream formula in the treatment of premature ovarian failure of kidney deficiency","volume":"14","author":"Lu","year":"2019","journal-title":"World J Integr Tradit West Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.16841\/j.issn1003-8450.2020.02.13","article-title":"Clinical observation on 30 cases of premature ovarian insufficiency with liver depression and kidney deficiency type treated by Yijing Tang","volume":"37","author":"Luo","year":"2020","journal-title":"J Gansu Univ Chin Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.2096-3327.2025.03.021","article-title":"Clinical study on Zishen Hugan formula in the treatment of premature ovarian failure with liver-kidney yin deficiency syndrome","volume":"22","author":"Ren","year":"2025","journal-title":"Chin J Ration Drug Use"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.16305\/j.1007-1334.2021.1907166","article-title":"Effect of Zhu's Bushen Huoxue formula on premature ovarian failure based on the correlation between Amh and Microrna-23a [Article in Chinese]","volume":"55","author":"Song","year":"2021","journal-title":"Shanghai J Tradit Chin Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.16305\/j.1007-1334.2021.1910010","article-title":"Ameliorative effect of Zhu's Tiaojing recipe on ovarian blood supply in Poi patients with type of kidney deficiency and blood stasis","volume":"55","author":"Sui","year":"2021","journal-title":"Shanghai J Tradit Chin Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.13863\/j.issn1001-4454.2021.12.041","article-title":"Efficacy and mechanism of Bushen Huoxue decoction combined with Femoston for premature ovarian insufficiency with kidney deficiency and blood stasis [Article in Chinese]","volume":"44","author":"Tang","year":"2021","journal-title":"J Chin Medicinal Materials"},{"key":"B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.16040\/j.cnki.cn15-1101.2021.03.044","article-title":"Clinical effect of Kuntai capsules for premature ovarian failure [Article in Chinese]","volume":"40","author":"Wang","year":"2021","journal-title":"Inner Mong J Tradit Chin Med"},{"key":"B41","article-title":"Efficacy of Bushen Culuan decoction for premature ovarian failure [Article in Chinese]","volume":"6","author":"Wang","year":"2019","journal-title":"J Clin Med Lit"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.16040\/j.cnki.cn15-1101.2021.01.029","article-title":"Clinical efficacy of Yishen Shugan decoction for premature ovarian insufficiency with kidney deficiency and liver depression [Article in Chinese]","volume":"40","author":"Wang","year":"2021","journal-title":"Inner Mong J Tradit Chin Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.11656\/j.issn.1672-1519.2024.05.04","article-title":"Regulatory effect of Bushen Huoxue formula on immune balance in patients with premature ovarian insufficiency with kidney deficiency and blood stasis [Article in Chinese]","volume":"41","author":"Wang","year":"2024","journal-title":"Tianjin J Tradit Chin Med"},{"key":"B44","article-title":"Clinical observation of modified Erxian decoction for amenorrhea due to premature ovarian failure with kidney deficiency and liver depression [Article in Chinese]","author":"Wang","year":"2022","journal-title":"Baojian Wenhui"},{"key":"B45","first-page":"39","article-title":"Bushen Huanjing formula for premature ovarian failure [Article in Chinese]","volume":"47","author":"Wen","year":"2015","journal-title":"Jiangsu J Tradit Chin Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1673-7202.2023.15.014","article-title":"Effects of Zhu's Tiaojing recipe on premature ovarian insufficiency and immune damage induced by inflammation","volume":"18","author":"Xia","year":"2023","journal-title":"World Chin Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1001-6910.2025.02.10","article-title":"Study of Bushen Tiaojing decoction for premature ovarian failure with liver depression and kidney deficiency [Article in Chinese]","volume":"38","author":"Xie","year":"2025","journal-title":"TCM Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.13422\/j.cnki.syfjx.2014210221","article-title":"Effect of Bushen Tiaojing formula on the reproductive axis in patients with premature ovarian failure [Article in Chinese]","volume":"20","author":"Xu","year":"2014","journal-title":"Chin J Exp Traditional Med Formulae"},{"key":"B49","article-title":"Effect of Bushen Tiaojing paste formula on sex hormone levels in patients with kidney-deficiency-type premature ovarian failure [Article in Chinese]","volume":"34","author":"Xu","year":"2017","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7661\/CJIM.2013.10.1332","article-title":"Treatment of premature ovarian failure patients by Bushen Tiaojing recipe combined hormone replacement therapy: a clinical observation","volume":"33","author":"Xu","year":"2013","journal-title":"Chin J Integr Tradit West Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.13193\/j.archtcm.2012.07.204.xuhj.079","article-title":"Clinical study of modified Yijing decoction for follicular-type premature ovarian failure [Article in Chinese]","volume":"30","author":"Xu","year":"2012","journal-title":"Chin Arch Tradit Chin Med"},{"key":"B52","first-page":"88","article-title":"Effect of the traditional Chinese medicine method of tonifying the kidney and nourishing blood on hormonal changes and clinical outcomes in patients with premature ovarian failure [Article in Chinese]","volume-title":"Chinese Science and Technology Journal Database (Citation Edition): Medicine and Health.","author":"Xue","year":"2026"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.2095-8803.2024.12.008","article-title":"To evaluate the effects of Zuogui pill combined with Gegen Heisu decoction on ovarian blood flow status and reserve function in patients with premature ovarian failure","volume":"11","author":"Ye","year":"2024","journal-title":"Pract Electron J Gynecol Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.13638\/j.issn.1671-4040.2018.12.044","article-title":"Efficacy of the kidney-tonifying and essence-replenishing method for improving ovarian reserve function in patients with premature ovarian insufficiency [Article in Chinese]","volume":"18","author":"Yu","year":"2018","journal-title":"Pract Clin J Integr Tradit Chin West Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.19368\/j.cnki.2096-1782.2019.18.130","article-title":"Observation on the therapeutic effect of Erxian decoction on early-onset ovarian insufficiency of spleen and kidney yang deficiency type","volume":"4","author":"Yuan","year":"2019","journal-title":"Syst Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7661\/j.cjim.20190125.101","article-title":"Clinical observation of Huoxue Zishen formula for immune premature ovarian failure with kidney deficiency and blood stasis [Article in Chinese]","volume":"39","author":"Zeng","year":"2019","journal-title":"Chin J Integr Tradit West Med"},{"key":"B57","article-title":"Efficacy analysis of Erxian decoction for improving symptoms and endocrine indexes of patients with premature ovarian failure","volume":"9","author":"Zeng","year":"2017","journal-title":"Clin J Chin Med"},{"key":"B58","article-title":"Clinical observation of Bushen Tiaogan Huoxue formula in 30 cases of premature ovarian failure [Article in Chinese]","volume":"25","author":"Zheng","year":"2009","journal-title":"Hunan J Tradit Chin Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3969\/j.issn.1673-9701.2025.14.012","article-title":"Clinical efficacy and mechanism of Zishen Shujing decoction for premature ovarian failure with kidney deficiency and liver depression [Article in Chinese]","volume":"63","author":"Zhou","year":"2025","journal-title":"China Mod Dr"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: A systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1721377","article-title":"The role of oocyte quality in explaining \"unexplained\" infertility","volume":"38","author":"Homer","year":"2020","journal-title":"Semin Reprod Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/812179","article-title":"Systematic reviews and meta-analyses of traditional Chinese medicine must search Chinese databases to reduce language bias","volume":"2013","author":"Wu","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081123","article-title":"Consort 2025 statement: Updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.855992","article-title":"The evaluation of ovarian function recovery following treatment of primary ovarian insufficiency: A systematic review","volume":"13","author":"Kuang","year":"2022","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1870487\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:55:32Z","timestamp":1785905732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1870487\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":64,"alternative-id":["10.3389\/fendo.2026.1870487"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1870487","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1870487"}}